ABSTRACT

   Typhoid fever (TF) is an acute systemic infection caused by Salmonella Typhi, Salmonella Para Typhi A and Salmonella Para Typhi B. It is transmitted by the fecal oral route mainly via contaminated food and water. The developing countries have high rate of morbidity and mortality due to Typhoid fever, epidemics take place in developed world also. There are increased incidences of multi drug resistant in S. typhi strains that has further complicated its management and only a few antibiotics are now effective in treatment of typhoid. We report that the aqueous extracts of fruit peel Citrus sinensis (L.) confer anti typhoid activity against Salmonella Typhi, Salmonella Para Typhi A and Salmonella Para Typhi B respectively on comparison with ciprofloxacin.



        

Key words:
Typhoid fever, Salmonella Typhi, Salmonella Para Typhi A , Salmonella Para Typhi B, anti typhoid activity, Citrus sinensis.
Copyright 2009  by "International Journal of Pharmaceutica Research and Development"    All Rights reserved    E-Mail: info@ijprd.com
Welcome to "International Journal of Pharmaceutical Research and Development"  i.e. "IJPRD"
HOW TO PREPARE   
YOUR PAPER
What's New | Feedback | Copyright and Disclaimer
Online Since : March 2009
TODAY IS
Abstract Content
Model Abstract
Summary Content
Model Summary

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
- : BACK TO CURRENT ISSUE OF JOURNAL :-
((( PREVIOUS ARTICLE
NEXT ARTICLE )))
[ VIEW FULL ARTICLE ] [PDF VIEW ]
December - 2010 / Volume - 2/Issue - 10
( Total Articles =17 )
December 2010 Issue
Past Issues

March 2009

April 2009

May 2009

June 2009

July 2009

August 2009

September 2009

October 2009

November 2009

December 2009

January 2010

February 2010

March 2010

April 2010

May 2010

June 2010

July 2010

August 10

September 10

October 10

November 10


December 2010
Article No 14
December - 2010 / Volume - 2 / Issue - 10 / Article No - 14 / Review Article

THALASSEMIA : A REVIEW

  S. R. Ghodekar1*,
N. D. Grampurohit1, S. S. Kadam1, R. M.Thorat1



1Vishal Institute of Pharmaceutical
Education And Research, Ale, Pune-412411.
Email:Srj.Ghodekar@Gmail.Com
S.R.Ghodekar
ABSTRACT

   Thalassemia is the name of a group of genetic blood disorders characterized by anemia due to enhanced red blood cell destruction.
Hemoglobin, the oxygen-carrying component of the red blood cells consists of two different proteins, an and a . If the body doesn't produce enough of either of these two proteins, the red blood cells become defective and cannot carry sufficient oxygen. The resulting anemia is usually severe with several health problems like enlarged spleen, bone deformities, fatigue and requires regular life-long transfusion, therapy and medical supervision.

Thalassemias can't be prevented because they're inherited, "inherited" means they are passed on from parents to children. However, these bleeding disorders can be found before birth through prenatal tests.
Thalassemia is a common inherited disease in the world. India accounts for 10% of the total world thalassemia population and approximately 1 in 30 in the general population is carrier of the mutated gene and the cases may increase as it is a hereditary disorder.
So, it is important to take into consideration about this disorder as it may prove deadly one. And thus the intensity of this disorder can be lowered by diagnosing and taking proper treatments.




        

Key words:
Thalassemia, Haemoglobin, Globin Chains, Chromosome 11 & Chromosome 16.